Share the post "Kashyap Tele-Medicines : Q4 2024 Financial Quarterly Report : YoY Sales Up 0 %, QoQ Down 15.22 %"
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 0 % in the past year, decrease in net sales/revenue by -15.22 %.
- Income over the Year and quarter:
- Profit over the Year and quarter: Significant improvement in profitability for Kashyap Tele-Medicines Limited. Notable increase of 540 % in net profit Year to Year, Kashyap Tele-Medicines Limited’s profitability dropped by -3300 % Quarter to Quarter.
- EPS over the Year and quarter:
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.039 Cr | Rs. 0.046 Cr | Rs. 0.039 Cr | -15.22 % | + 0 % |
| Expenses | Rs. 0.05 Cr | Rs. 0.04 Cr | Rs. 0.07 Cr | + 75 % | + 40 % |
| Operating Profit | Rs. -0.01 Cr | Rs. 0.01 Cr | Rs. -0.03 Cr | -400 % | -200 % |
| OPM % | -25.64 % | 21.74 % | -76.92 % | -98.66 % | -51.28 % |
| Other Income | Rs. -0.01 Cr | Rs. -0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Profit before tax | Rs. -0.02 Cr | Rs. 0.01 Cr | Rs. -0.03 Cr | -400 % | -50 % |
| Tax % | -33.33 % | 0 % | -0 % | 0 % | + 33.33 % |
| Net Profit | Rs. -0.01 Cr | Rs. 0 Cr | Rs. -0.03 Cr | 0 % | -200 % |
| EPS in Rs | Rs. 0 | Rs. 0 | Rs. -0.01 | 0 % | 0 % |
Today, we’re looking at Kashyap Tele-Medicines Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 0 %. However, it did see a marginal slip of -15.22 % from the previous quarter. Expenses ticked up slightly by 75 % quarter-on-quarter, aligning with the annual rise of 40 %. Operating profit, while down -200 % compared to last year, faced a quarter-on-quarter dip of -400 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -51.28 %, but a shrinkage of -98.66 % sequentially. Profit before tax declined annually by -50 % but saw a reduction from the preceding quarter by -400 %.
Tax expenses as a percentage of profits increased slightly by 33.33 % compared to last year, Net profit fell by -200 % year-on-year In summary, Kashyap Tele-Medicines Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.039 Cr | Rs. 0.046 Cr | Rs. 0.039 Cr | -15.22 % | + 0 % |
| Expenses | Rs. 0.05 Cr | Rs. 0.04 Cr | Rs. 0.07 Cr | + 75 % | + 40 % |
| Operating Profit | Rs. -0.01 Cr | Rs. 0.01 Cr | Rs. -0.03 Cr | -400 % | -200 % |
| Net Profit | Rs. -0.01 Cr | Rs. 0 Cr | Rs. -0.03 Cr | 0 % | -200 % |
| EPS in Rs | Rs. 0 | Rs. 0 | Rs. -0.01 | 0 % | 0 % |
In reviewing Kashyap Tele-Medicines Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 0 % year-on-year growth, although there was a slight dip of -15.22 % from the previous quarter. Expenses rose by 40 % compared to the previous year, with a 75 % increase quarter-on-quarter. Operating Profit dropped by -200 % annually, and saw a -400 % decrease from the last quarter.
Net Profit showed yearly decrease of -200 %, In essence, while Kashyap Tele-Medicines Limited faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
0
3-Year Profit
0
5-Year Profit
0
10-Year Profit
2.93
Current Price
14.0
Market Cap
In analyzing the financial results for the company marked by BSE code 531960, a clear trend emerges. Over a five-year span, the company reported a profit of 0 percents, which increased to 0 percents in the most recent three-year period, suggesting a strong performance in the early stages of this timeframe. However, this success has been overshadowed by a trailing twelve-month (TTM) loss of 0 percents, signaling significant recent challenges. Compounding this issue is the fact that the company has not reported any sales during any of the timeframes analyzed, raising important questions about its operational model and the sustainability of its current strategies. Investors have been equally wary, as reflected in the stock price performance. The company’s stock traded at 0 percents over the past five years but has recently decreased to 50 percents, indicating a loss of market confidence. Over the last decade, the stock price was at 2 percents, pointing to longer-term concerns that could affect the company's future prospects.
With a market capitalization of ₹14.0 crore, the company’s stock is currently trading at ₹2.93, having fluctuated within a range of ₹3.23 / 1.41 over the years. The stock's P/E ratio of reflects a relatively high valuation compared to its earnings, which could suggest strong future growth expectations or heightened investor demand. The company’s book value is ₹0.13, representing the total value of its assets on a per-share basis, while the dividend yield of 0.00% offers a modest return to shareholders. ROCE, at -4.58%, highlights the company's efficient use of capital in generating profits, while ROE at -4.58% underscores its ability to generate returns for shareholders. The debt-to-equity ratio of 0.00 is very low, indicating conservative financial management and minimal reliance on borrowed funds. Despite this, the company shows a negative net cash flow of ₹0.00 crore, which could point to cash management challenges or recent heavy investments. The Piotroski score of 3.00 suggests moderate financial strength, while the Graham Number, pegged at ₹, offers a rough estimate of the stock's intrinsic value. The Price-to-Book (P/B) ratio of 21.8 signals that the stock is trading at a premium, which might reflect investor confidence in the company's growth trajectory.
